Table 1 Baseline characteristics
| Characteristic | Patients ( N =26) |
|---|---|
| Age, median years (range) | 60 (34–73) |
| Sex, n (%) | |
| Male | 16 (62) |
| Female | 10 (38) |
| Race, n (%) | |
| Caucasian | 22 (85) |
| African American | 3 (12) |
| Unknown | 1 (4) |
| ECOG performance status, n (%) | |
| 0 | 15 (58) |
| 1 | 11 (42) |
| Primary tumour type, n (%) | |
| Biliary tract | 6 (23) |
| NSCLC | 3 (12) |
| Salivary gland | 3 (12) |
| Bladder | 2 (8) |
| Breast | 2 (8) |
| Oesophagus | 2 (8) |
| Pancreas | 2 (8) |
| Adenocarcinoma of unknown primary | 1 (4) |
| Othera | 5 (19) |
| Number of prior lines of chemotherapy, n (%) | |
| 0 | 5 (19) |
| 1 | 9 (35) |
| 2 | 11 (42) |
| 3 | 1 (4) |
| Patients with prior taxane therapy, n (%) | |
| Paclitaxel | 7 (27) |
| Docetaxel | 2 (8) |
